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Abstract
Background: Activation by extracellular ligands of G protein-coupled (GPCRs) and tyrosine kinase receptors (RTKs),
results in the generation of second messengers that in turn control specific cell functions. Further, modulation/
amplification or inhibition of the initial signalling events, depend on the recruitment onto the plasma membrane
of soluble protein effectors.
High throughput methodologies to monitor quantitatively second messenger production, have been developed over
the last years and are largely used to screen chemical libraries for drug development. On the contrary, no such high
throughput methods are yet available for the other aspect of GPCRs regulation, i.e. protein translocation to the plasma
membrane, despite the enormous interest of this phenomenon for the modulation of receptor downstream functions.
Indeed, to date, the experimental procedures available are either inadequate or complex and expensive.
Results: Here we describe the development of a novel conceptual approach to the study of cytosolic proteins
translocation to the inner surface of the plasma membrane. The basis of the technique consists in: i) generating chimeras
between the protein of interests and the calcium (Ca
2+)-sensitive, luminescent photo-protein, aequorin and ii) taking
advantage of the large Ca
2+ concentration [Ca
2+] difference between bulk cytosolic and the sub-plasma membrane rim.
Conclusion: This approach, that keeps unaffected the translocation properties of the signalling protein, can in
principle be applied to any protein that, upon activation, moves from the cytosol to the plasma membrane.
Thus, not only the modulation of GPCRs and RTKs can be investigated in this way, but that of all other proteins
that can be recruited to the plasma membrane also independently of receptor activation.
Moreover, its automated version, which can provide information about the kinetics and concentration-dependence
of the process, is also applicable to high throughput screening of drugs affecting the translocation process.
Background
Translocation of proteins, from the bulk of the cytosol to
the plasma membrane, is a critical step in the transfer of
information from membrane-embedded receptors to the
cell interior. Just to cite a few examples, both RTKs and
GPCRs recruit, upon activation, effector proteins such as
SH2-containing adaptor proteins [1], various enzymes and
the desensitizing proteins arrestins [2]. In addition, other
classes of effector proteins, such as those of the broad pro-
tein kinase C family [3], are activated upon translocation
to the plasma-membrane microenvironment, indepen-
dently of receptor binding. Detailed knowledge of the
translocation of specific proteins, not only in physiological,
but also in pathological conditions, may therefore high-
light key aspects of defined signalling pathways. Impaired
or excessive translocations of specific proteins are known
in fact to play important roles in the pathogenesis of dis-
eases (see for example the case of the beta 2 isoform of
protein kinase C, PKCbII, in hyperglycemia and vascular
complications of diabetes mellitus [4,5]).
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investigate translocation were immunocytochemistry
and subcellular fractionation followed by western blot-
ting of the isolated fractions. Although adequate to
reveal the existence of the process these approaches suf-
fered of many drawbacks and limitations: possible arte-
facts, low time and space resolution, low sensitivity,
problems in the precise identification of the cellular
structures involved, that have limited their use to the
low-throughput investigation.
The introduction of GFP fluorescent probes and, more
recently, of the restoration of the b-galactosidase activity
following complementation of two inactive fragments of
the enzyme [6], has made possible the kinetics of protein
translocation to be investigated in living cells. However,
with GFP probes the increases in fluorescence are rela-
tively small, often mixed up by the interference of endo-
genous fluorophores. The novel b-galactosidase
complementation procedure is intrinsically complex.
Two chimeric reporters, the translocating protein and its
specific target, localized in a precise subcellular structure,
are necessary. The translocation process is inevitably
influenced by the binding of the two fragments and the
proteins addressed to unknown targets cannot be investi-
gated, limiting this technique for a screening purpose.
Here we have employed a new procedure based on the
use of chimeric constructs where the translocation pro-
tein is included in frame with aequorin, a well known
bioluminescent photoprotein, per se aC a
2+ probe
(Figure 1A), used so far primarily for the study of Ca
2+
homeostasis [7]. The translocation of the aequorin-con-
taining chimera to the sub-plasmalemma rim is able in
itself to detect such signal because of the much higher
[Ca
2+] (at least 1 order of magnitude with respect to the
rest of the cytosol [8]) generated locally upon cell stimu-
lation (Figure 1B). Given the strength of the light signal
emitted by aequorin upon Ca
2+ binding (proportional to
almost the 3rd power of the [Ca
2+] [7]), and the lack of
bioluminescent molecules within mammalian cells, the
procedure has an excellent signal-to-noise ratio.
Here we report results obtained by following the
translocation of two interesting proteins (Figure 1C): b-
arrestin-2 (barr2), addressed to a precise receptor target;
and PKCbII, for which no protein target is known in the
plasma membrane. By the use of a robot the procedure
could be made more powerful, providing information
about specific aspects of the translocation process,
including its time-course and the dose-dependence of its
activation.
Results
Generation of chimeric probes
Cohesive cDNA constructs, encoding aequorin and b-
arrestin-2 or PKCb were fused in frame and the reporter
chimeric proteins are denominated barr2-AEQ and
PKCb-AEQ (Figure 1C), respectively.
The initial experiments were carried out to establish,
using the classical approaches, i.e. immunocytochemistry
(Figure 2) and subcellular fractionation followed by wes-
tern blot of the fractions (not shown), whether the
aequorin tag does affect or not the activity-dependent
translocation of the two proteins investigated, barr2 and
PKCbII, after agonists or pharmacological stimulations.
The cells used for the studies were HeLa, that do
express only very low levels of endogenous b-adrenergic
receptor (bAR). The barr2-AEQ cDNA was therefore
co-transfected transiently with either the b2AR [9] or an
empty vector, and the distribution of barr2-AEQ probe
was established before and after stimulation with the
receptor agonist, isoprenaline (40 μM, Figure 2A).
In resting cells barr2-AEQ exhibited a diffuse cyto-
plasmic distribution (Figure 2A, upper images); upon
isoprenaline addition the chimera was rapidly (within 1
min) translocated to the periphery, however only in the
cells transfected with the b2AR (see the bottom right
Figure 1 Schematic representation of the concept behind the
new technology. A. The Ca
2+-sensitive photoprotein aequorin in
the active form. includes an apoprotein and a covalently bound
prosthetic group (coelenterazine). When Ca
2+ ions bind to three
high-affinity sites (EF-hand type), aequorin undergoes an irreversible
reaction, in which a photon is emitted. B. Translocation studies can
be performed on aequorin-tagged proteins, thanks to the different
[Ca
2+] present in distinct subcellular compartments. An aequorin-
tagged signalling protein (proteinX-Aeq, green/orange sticks)
located in the cytosol (light blue) translocates, upon stimulation in a
receptor dependent or independent manner, to the plasma
membrane (dark blue), where [Ca
2+] is at least 1 order of magnitude
higher then the cytosol, giving rise to an easily detectable increase
in light emission (yellow flashes).
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the luminescence assays with this chimera was therefore
of 1 min.
Other batches of HeLa cells were transfected with the
PKCbII-AEQ cDNA and treated with phorbol 12-myris-
tate 13-acetate (PMA), a potent activator of classical
PKCs [10]. In this case, the translocation of the probe,
from its diffuse distribution at rest to a peripheral distri-
bution, required less than 5 min of PMA treatment (1
μM, Figure 2B).
These times match those reported previously for the
translocations of the two proteins upon the two types of
stimulation. Thus, the aequorin tag does not affect the
activity-dependent translocation of either investigated
protein.
Analysis of barr2-AEQ and PKC-AEQ translocation by
luminescence assay
To confirm the validity of the aequorin chemilumines-
cence procedure to reveal the differential distribution of
a protein in the subplasmalemma rim and the cytosol,
HeLa cells were seeded onto 13 mm coverslips and tran-
siently transfected with two chimeric aequorin cDNAs,
one encoding a constitutively cytosolic probe (cyt-AEQ)
[11], the other a probe addressed to the cytosolic face of
t h ep l a s m am e m b r a n e( S N A P - A E Q )[ 8 ] .T h i r t ys i xh r
after transfection, the probes were reconstituted adding
5 mM coelenterazine in Krebs-Ringer modified Buffer
(KRB) and the coverslips were transferred to the cham-
ber of a single-well luminometer. With both the cyt-
AEQ and SNAP-AEQ probes the traces recorded in Ca
2
+- f r e eb u f f e r( K R B / E G T A )w e r es l i g h t l ya b o v eb a c k -
ground (< 100 cps) (Figure 3). Upon re-addition of 1
mM CaCl2 (KRB/Ca
2+), the rapid Ca
2+ influx (induced
by the store depletion occurred during Ca
2+-free incuba-
tion) caused an increase in light emission. As expected,
such an increase was over 10-fold greater in the cells
expressing the SNAP-AEQ than in those expressing the
cyt-AEQ probe (Figure 3, light and dark gray lines
respectively). Indeed, given the steep Ca
2+ response
curve, significant light emission is detected only when
the aequorin pool (or a significant part of it) is exposed
to high [Ca
2+]. Accordingly, the probe for bulk cytosolic
[Ca
2+] shows a very small light emission upon the large
Ca
2+ rise following Ca
2+ readdition to cell maintained
in Ca
2+-free media (i.e. upon capacitative Ca
2+ entry).
Figures 3A and 3B illustrate also the results obtained
with the cells co-transfected with the barr2-AEQ and
b2AR cDNAs, treated or not with isoprenaline (40 μM)
for 1 min prior to Ca
2+ re-addition. In the untreated cells
the increase of light emission upon Ca
2+ re-addition was
only slightly higher than that observed in the cells trans-
fected with cyt-AEQ (Figure 3A, black line), whereas in
those treated with the b2AR agonist it was much higher,
almost as high as that observed with the plasma mem-
b r a n ea d d r e s s e dS N A P - A E Qp r o b e( F i g u r e3 B ,b l a c k
line). Similar results were obtained in the cells trans-
fected with the PKCbII-AEQ cDNA and then tested
according to the same protocol, with the exception that
the PKC stimulant, PMA (1 μM), was administered for 5
min before Ca
2+ re-addition (black traces). Also in this
case the emission peak of the stimulated cells was nearly
10-fold higher than that of resting cells, reaching levels
analogous to those of the SNAP-AEQ-transfected cells
(compare the traces of Figure 3C and 3D).
Automatization assay
The power of the approach was further investigated by
carrying out automated tracing assays in a luminescence
plate reader, using 24-well plates governed by a robot.
Figure 4 illustrates results obtained in barr2-AEQ/b2AR
cDNAs expressing HeLa cells stimulated with isoprena-
line (40 μM). At first, we verified whether in this experi-
mental setup, in which luminescence is not recorded in
the injection phase and thus the upstroke of the rise is
βarr2-AEQ / βAR
   PKCβII-AEQ
Not
Treated
PMA
Isoprenaline
βarr2-AEQ
Not
Treated
A
B
5μm
Figure 2 Confocal microscopy analyses of probes translocation.
A. Immunocytochemistry analyses of barr2-AEQ localization in HeLa
cells, either co-transfected with b2AR (right panels) or with an
empty vector (left panels), in control condition (upper panels) and
upon 40 μM isoprenaline stimulation (1 min) in KRB/EGTA (lower
panels). After 1 minute of isoprenaline stimulation, the typical re-
localization at the plasma membrane, in almost 80% of the cells,
was observed only for barr2-AEQ co-expressed with b2AR (lower
right panel) because the expression of the endogenous receptors
targets of barr2 is very low in these cells. B. PKCbII-AEQ localization
in HeLa cells before (cytosolic, left panel) and after 5 minutes of 1
μM PMA treatment in KRB/EGTA (plasma membrane, right panel).
After PMA stimulation almost all (≥ 95%) of the cells showed a
PKCbII-AEQ plasma membrane translocation.
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Figure 3 Assessing the system functioning. A-B. HeLa cells expressing bAR and transfected with barr2-AEQ or with control probes cyt-AEQ
and SNAP-AEQ were perfused with a Ca
2+-free buffer (KRB/EGTA), showing light emission values slightly above the background (< 100 cps). In
control conditions (A) upon Ca
2+ re-addition to the medium (KRB/Ca
2+) the light emission values changed markedly only for SNAP-AEQ probe,
as expected; while upon isoprenaline stimulation (B) also the barr2-AEQ probe gave rise to a similar light emission increase, confirming probe
translocation (barr2-AEQ control peak 1,730 ± 356 cps n = 9, barr2-AEQ + isoprenaline peak 6,951 ± 797 cps n = 9; cyt-AEQ control peak 756 ±
36 cps n = 9, cyt-AEQ + isoprenaline peak 562 ± 37 cps n = 9; SNAP-AEQ control peak 8,040 ± 353 cps n = 9, SNAP-AEQ + isoprenaline peak
7,930 ± 80 cps n = 9). C-D. A similar behaviour was observed in HeLa cells over-expressing the PKC bII-AEQ probe. Only upon PMA stimulation
(D) an increase in light emission after Ca
2+ re-addition was observed, confirming the efficacy of the assay (PKCbII-AEQ control peak 4,115 ± 1,041
cps n = 12, PKCbII-AEQ + PMA 44,140 ± 7,858 cps n = 15; cyt-AEQ control peak 3,884 ± 785 cps n = 10, cyt-AEQ + PMA peak 3,501 ± 519 cps n
= 9; SNAP-AEQ control peak 42,517 ± 5,012 cps n = 12, SNAP-AEQ + PMA peak 44,782 ± 5,749 cps n = 11). All results represent cell populations
measurements and are expressed as mean ± standard error (SE). The traces showed correspond to a sample representative of the mean
obtained from all experiments. n = number of samples (wells) analyzed from at least ten independent experiments.
Giorgi et al. BMC Cell Biology 2011, 12:27
http://www.biomedcentral.com/1471-2121/12/27
Page 4 of 8lost, a reproducible difference in aequorin light emission
can be recorded when the barr2-AEQ chimera translo-
cates to the plasma membrane. Figures 4A and 4B show
that this is indeed the case. The recording of the
aequorin peaks elicited by Ca
2+ re-addition to KRB in
each of the multi-well plates was in fact much higher in
the treated cells than in the controls. Additional
parameters were investigated. Figure 4C shows the time-
course of the barr2-AEQ translocation to the plasma
membrane upon agonist addition. The maximal
response, observed after approx. 30 s of stimulation, was
followed by a persistent plateau. The concentration
dependence of the isoprenaline-induced translocation of
barr2-AEQ is illustrated in Figure 4D. Detectable
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Figure 4 Automated tracing of plasma membrane translocation aequorin responses. A. The barr2-AEQ probe was used to perform typical
screening assays in an automated luminescence plate reader. Panel A shows the recording of the aequorin peaks elicited by Ca
2+ re-addition to
the KRB bathing HeLa cells co-transfected with barr2-AEQ and bAR. The cells were pre-treated (1 min) or not with isoprenaline (40 μM). The
same data are represented in (B) as mean of integral response area (barr2-AEQ control 11,909 ± 2,351 cps n = 15, barr2-AEQ + isoprenaline
151,300 ± 24,090 cps n = 11). Panel C illustrates the time course of barr2-AEQ probe translocation to the plasma membrane of HeLa cells co-
transfected with bAR. The light responses were induced by addition (dotted line) or not (solid line) of isoprenaline 40 μM in KRB/Ca
2+. D.
Concentration response curve of cells co-transfected with barr2-AEQ and bAR, pretreated with various concentrations of isoprenaline. The
aequorin light emission responses were triggered by reintroduction of Ca
2+ as in Figure 3.
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Page 5 of 8increases were observed at concentrations as low as 10
-8
M and maximal responses at 10
-4 M. Interestingly, this
concentration response curve matches closely the curve
of barr2 binding to the b2AR reported previously in
CLC12 cells using the b-galactosidase complementation
procedure [12].
Discussion
The possibility of randomly developing thousands of
new drugs by combinatorial chemistry, and to rapidly
d e v e l o pl e a dc o m p o u n d s ,r e p r e s e n t sa ni m m e n s ev a l u e
in pharmaceutical research. To take full advantage of
this technological potential, however, screening meth-
odologies must be available that are robust, reproducible
and amenable to medium/high throughput applications.
In some cases (see the analysis of Ca
2+ homeostasis), the
tools commonly employed in basic research, the intra-
cellularly trappable fluorescent dyes, such as fura-2 or
Fluo-3, proved highly effective in high-throughput
screenings, and are commonly employed for the devel-
opment of the vast array of drugs acting on Ca
2+ signal-
ling [13]. These probes, however, can monitor one of
the earliest events following receptor activation, but the
data thus obtained are difficult to interpret for the
understanding of other downstream signalling processes:
protein translocation to the plasma-membrane is a typi-
cal example: it is a signalling step common to many
diverse pathways (from RTKs and GPCRs, to the activa-
tion of specific enzymatic effectors) [14-17], but the cur-
rently available probes and techniques do not allow
wide-range screenings or require complex and error-
prone data analyses.
In this contribution, we have developed a novel
approach that utilizes a Ca
2+ sensitive photoprotein,
aequorin, for a task different from the measurement of
calcium signalling itself, and stems from an experimen-
tal observation and a technical aspect. The first is the
measurement of the [Ca
2+] in the thin rim of cytoplasm
beneath the plasma membrane, where both at rest and
in particular upon stimulation the flow of Ca
2+ from the
extracellular medium produces a local [Ca
2+]t h a ti sa t
least one order of magnitude higher than in the deeper,
bulk cytosol [8]. Thus, aequorin can act as a tag of pro-
tein translocation, as the simple movement of the tagged
protein to the plasma membrane markedly changes the
[Ca
2+] to which it is exposed. The second startpoint of
the new methodology is an intrinsic property of the
photoprotein, i.e. the logarithmic correlation between
[Ca
2+] and light emission [7]. This property, that greatly
increases light output with relatively small [Ca
2+]
increases, represents in most cases an experimental con-
cern, as it tends to amplify the contribution of highly
responding cells or cell domains in signalling studies. In
the case of the new methodology reported in this paper,
the high reponsiveness of the photoprotein represents a
major plus, as it allows to detect protein translocation
(e.g. a cytosolic adapter of the plasma membrane recep-
tor) also when only a fraction of the protein actually
moves within the cell. Together with the other advan-
tages of a luminescence-based probe (no background
signal, for the lack of other luminescent molecules
w i t h i nt h ec e l l ,t h es i m p l eg e o m e t r yo ft h ed e t e c t i o n
apparatus, etc.), this property provides a striking advan-
tage over existing methodologies (GFP-based transloca-
tion assays, immunoblotting of subcellular fractions,
etc.).
We have thus developed aequorin-based probes, that
allow to detect the translocation of two classes of signal-
ling proteins, a receptor adapter (b-arrestin, recognizing
all classes of GPCRs) [18] and an important enzyme
transducer, a member of the broad and complex family
of PKC [3]. The engineered probes, barr2-AEQ and
PKCb-AEQ were uniformly distributed in the cytosol at
rest, and translocated to the plasma membrane upon sti-
mulation with suitable compounds (isoprenaline and
PMA respectively), triggering a dramatic increase in
aequorin photon emission. In both cases, the probes
proved very effective also with automated multi-well
detectors. For b-arrestin, the pharmacological character-
ization of a receptor agonist proved its reliability, not
only in the identification of active compounds, but also
in the complete assessment of its functional properties.
Conclusions
Overall, the understanding of the subcellular heteroge-
neity of Ca
2+ homeostasis and the experience with a
recombinant luminescent Ca
2+ p r o b eh a sa l l o w e du st o
develop a robust, highly reproducible methodology for
monitoring, in research applications and screening plat-
forms, the translocation of specific proteins to the
plasma membrane. This innovation will allow decipher-
ing, and pharmacologically tackling, a critical step in a
wide variety of signalling pathways including the whole
complement of GPCRs and RTKs and kinases recruited
to the plasma membrane independently of receptor acti-
vation [16,17]. This cellular assay, based on a single
reporter protein and the unique single-to-noise ratio of
the luminescent probe, meets the expanding demand for
cost-effective screening procedures. It may therefore
prove a highly valuable tool for identifying new
blockbuster drugs in compound libraries of thousands
of chemicals.
Methods
Plasmids and sequences
The sequence coding for the bovine b-arrestin-2 protein
was a gift of dr. V. Schiaffino (Milan, Italy). The cDNA
was amplified with the following primers: forward, 5’-
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Page 6 of 8GGGTACCGCCACCATGGGGGAGAAACCC-3’ (KpnI
site underlined); reverse, 5’-GAAGCTTCATGCAGA
ACTGGTCGTC-3’ (HindIII site underlined), and then
subcloned in the pSCA vector (StrataClone™). The
sequence was excised from the pSCA vector and
inserted in frame upstream of the cDNA coding for
aequorin protein into the pcDNA3 vector, previously
cut KpnI-HindIII.
T h es e q u e n c ec o d i n gf o rt h eb2 adrenergic receptor
was amplified with the following primers: forward, 5’-
GCGGCCGCGCCACCATGGGGCAACCCGGGAA-3’
(NotI site underlined); reverse, 5’-CCGGATTCCGGT-
TACAGCAGTGAGTCATTTGTAC-3’ (BamHI site
underlined), subcloned in the pSCA vector and finally
cloned into the pcDNA3 vector previously cut EcoRI.
cyt-AEQ [11], and aequorin targeted to the subplasma-
membrane region, SNAP-AEQ [8] were generated as
previously described.
The PKCbII-AEQ probe was constructed cloning
upstream the aequorin cDNA in pcDNA3 vector, pre-
viously cut KpnI, the sequence coding for the PKCbII,
excised KpnI from the chimera PKCbII -GFP, present in
our laboratories [5].
Cell culture and transfection
HeLa cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM), supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine, 0.25 mg/l benzylpeni-
cillin solution, 10 U.I./I streptomycin solution. For
aequorin measurements 50,000 cells were seeded either
in 24-well plate Falcon or onto 13 mm glass coverslips;
for immunofluorescence detection 100,000 cells were
seeded on 24 mm glass coverslips. At 50% confluence
the cells were transfected using the calcium-phosphate
technique:
- media was replaced on each well, 1 h before trans-
fection, with 1 or 2 ml of fresh media (DMEM + 10%
FBS + pen/strep)
- cells were transfected using 4 ug (13 mm or 24 well)
or 8 ug (24 mm) of total DNA
- day after medium was replaced and experiments
were performed 36 h after transfection.
Immunofluorescence analysis
Cells, seeded onto 24 mm coverslips, were transiently
transfected with a total amount of 8 μg of the appropri-
ate plasmid DNAs (barr2-AEQ and b2AR/empty vector
in a 1:3 ratio or PKCbII-AEQ alone). 36 h after transfec-
tion cells were stimulated with isoprenaline (40 μM, 1
min) or PMA (1 μM, 5 min), washed twice in PBS and
fixed for 20 min with 4% paraformaldehyde in PBS at
room temperature, supplemented with quenching solu-
tion (0.1 M glycine in PBS) for 10 min, washed and per-
meabilized with 0.2% Triton X-100 for 20 min, rinsed
three times with PBS and incubated for 90 min with 2%
BSA in PBS to block nonspecific binding sites. The pro-
teins of interest were identified with primary polyclonal
rabbit anti-arrestin IgG (1:500, Calbiochem, UK) or a
monoclonal mouse anti-PKCbII (1:200, Santa-Cruz Bio-
tec., CA, USA) antibodies in PBS, 2% BSA, incubated
overnight at 4°C in a wet chamber and revealed with the
AlexaFluor 594 anti-rabbit and anti-mouse antibodies
(Invitrogen, Molecular Probes, CA, USA), respectively,
diluted at 1:1000 in PBS, 2% BSA. After washing, the
cells were imaged with a Zeiss LSM 510 Confocal Laser
Scanning Microscope (Carl Zeiss, Jena, Germany).
Aequorin assay with single-well luminometer
Cells were transfected with a total amount of 4 μg of the
appropriate plasmid DNAs (barr2-AEQ/cyt-AEQ/SNAP-
AEQ and b2AR in a 1:3 ratio or PKCbII-AEQ/cyt-AEQ/
SNAP-AEQ alone). In order to potentiate Ca
2+ influx
and thus Ca
2+ level just beneath the plasma membrane,
36 h after transfection cells were incubated for 1 h at
37°C, in KRB/EGTA (Krebs-Ringer modified buffer:
NaCl 125 mM, KCl 5 mM, Na3PO4 1 mM, MgSO4 1
mM, glucose 5.5 mM, HEPES 20 mM, pH 7.4/EGTA
100 μM,) supplemented with 5 μM coelenterazine for
aequorin reconstitution. Cells were then stimulated with
isoprenaline 40 μM for 1 min or PMA 1 μMf o r5m i n
and light emission was measured restoring Ca
2+ to the
extracellular medium perfusing cells with KRB plus 1
mM CaCl2. To terminate the experiments and discharge
the remaining aequorin, the medium was replaced with
a water solution containing 100 μM digitonin and 10
mM CaCl2. All results are expressed as mean ± standard
error (SE).
Aequorin assay with automated luminometer
After the transfection and reconstitution procedures,
isoprenaline 40 μM was added for 1 min before putting
the multi-well plate in the instrument (MicrobetaJET,
PerkinElmer, CA, USA). KRB supplemented with 2 mM
CaCl2 was then injected and luminescence was recorded
for 60 s. To terminate the experiments and discharge
the remaining aequorin, a water solution containing 500
μM digitonin and 50 mM CaCl2 was injected.
To follow the kinetics of barr2-AEQ translocation, iso-
prenaline 40 μM was added at the KRB/Ca
2+ injected.
To generate the concentration response curve, cells
were treated with increasing concentration of isoprena-
line (0.1-100 μM). All results are expressed as mean ±
standard error (SE).
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